Renal Cell Carcinoma

— —

Nizar M. Tannir (Associate Professor, and Deputy Department Chair, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center)

Renal Cell Carcinoma

Nizar M. Tannir (Associate Professor, and Deputy Department Chair, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center)

$125.95

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Oxford University Press Inc
17 November 2014

Oncology; Renal medicine & nephrology; Radiology

Series: Oxford American Oncology Library

While patients with metastatic renal cell carcinoma (mRCC) are now living longer with improved quality of life, the success of novel therapies for mRCC has created challenges for practicing oncologists. Many patients who initially respond to targeted therapies ultimately develop progressive disease due to acquired resistance to these agents. Additionally, some patients do not respond at all to any of the currently approved targeted agents, underscoring the need for continued and concerted efforts to identify other relevant targets and pursue alternative therapeutic strategies. Part of the Oxford American Oncology Library, Renal Cell Carcinoma is a concise handbook that addresses the complex management of patients with mRCC. The book begins with a review of the epidemiology, pathology, and biology of renal cell carcinoma followed by chapters on specific targeted therapies and managing complications. The final chapters discuss supportive and integrative care and emerging therapies.

Edited by: Nizar M. Tannir (Associate Professor and Deputy Department Chair Department of Genitourinary Medical Oncology Division of Cancer Medicine The University of Texas MD Anderson Cancer Center)
Imprint: Oxford University Press Inc
Country of Publication: United States
Dimensions: Height: 204mm, Width: 129mm, Spine: 12mm
Weight: 220g
ISBN: 9780199988136
ISBN 10: 0199988137
Series: Oxford American Oncology Library
Pages: 210
Publication Date: 17 November 2014
Audience: Professional and scholarly , Undergraduate
Format: Paperback
Publisher's Status: Active

1. Epidemiology of Renal Cell Carcinoma ; 2. Pathology of Renal Cell Carcinoma ; 3. Biology of Renal Cell Carcinoma ; 4. Inherited Renal Cell Cancers ; 5. Interventional Radiology Procedures in Renal Cell Carcinoma ; 6. Management of Small Renal Masses and Early-Stage Renal Cell Carcinoma ; 7. Staging and Surgical Management of Locally Advanced Renal Cell Carcinoma and the Role of Adjuvant and Neoadjuvant Therapy ; 8. Integration of Targeted Therapy with Cytoreductive Nephrectomy and Metastasectomy in the Management of Metastatic Renal Cell Carcinoma ; 9. Immunotherapeutic Approaches for Metastatic Conventional-Type Renal Cell Carcinoma ; 10. Targeted Therapies for Metastatic Conventional-Type Renal Cell Carcinoma ; 11. Systemic Therapies for Metastatic Renal Cell Carcinoma of Variant Histology ; 12. Prognostic and Predictive Biomarkers in Renal Cell Carcinoma ; 13. Management of Complications of Targeted Therapies for Metastatic Renal Cell Carcinoma ; 14. The Role of Traditional and Stereotactic Radiation in Metastatic Renal Cell Carcinoma ; 15. Supportive Care in Advanced Renal Cell Carcinoma ; 16. Integrative Medicine in the Management of Renal Cell Carcinoma ; 17. Emerging Therapies and Future Directions in Renal Cell Carcinoma

Associate Professor, and Deputy Department Chair, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas